How big is the Australia Pharmaceuticals Market?

The Australia Pharmaceuticals Market size is expected to reach USD 13.21 billion in 2024 and grow at a CAGR of 6.25% to reach USD 17.89 billion by 2029. Read More

What is the current Australia Pharmaceuticals Market size?

In 2024, the Australia Pharmaceuticals Market size is expected to reach USD 13.21 billion. Read More

Who are the key players in Australia Pharmaceuticals Market?

Abbvie Inc., Amgen Inc., AstraZeneca plc, Eli Lilly & Co. and Pfizer Inc. are the major companies operating in the Australia Pharmaceuticals Market. Read More

What years does this Australia Pharmaceuticals Market cover, and what was the market size in 2023?

In 2023, the Australia Pharmaceuticals Market size was estimated at USD 12.38 billion. The report covers the Australia Pharmaceuticals Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Australia Pharmaceuticals Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the challenges for foreign pharma companies entering the Australian Market?

The challenges for foreign pharma companies entering the Australian Market are a) Competition b) Regulatory hurdles c) Potential need for local partnerships Read More

What are the challenges for foreign pharma companies entering the Australian Market?

The challenges for foreign pharma companies entering the Australian Market are a) Competition b) Regulatory hurdles c) Potential need for local partnerships Read More

Australia Pharmaceuticals Market Share

Statistics for the 2023 & 2024 Australia Pharmaceuticals market share, created by Mordor Intelligence™ Industry Reports. Australia Pharmaceuticals share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Australia Pharmaceuticals Industry

The Australian pharmaceutical market is highly competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. Some of the key companies currently dominating the market are Abbvie Inc., Amgen Inc., Pfizer Inc., AstraZeneca, and Eli Lilly and Company.